Add-on treatment of GLP-1 based therapy in patients with type 2 diabetes treated with insulin: an observational study

被引:0
|
作者
Zandee, W. T. [1 ]
Sleddering, M. A. [2 ]
Jazet, I. [2 ]
Bootsma, A. H. [1 ]
Geelhoed-Duijvestijn, P. H. L. [1 ]
机构
[1] Med Ctr Haaglanden, The Hague, Netherlands
[2] Leiden Univ, Med Ctr, NL-2300 RA Leiden, Netherlands
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
731
引用
收藏
页码:S299 / S299
页数:1
相关论文
共 50 条
  • [1] PS5 - 24. Add-on treatment of GLP-1 agonists in type 2 diabetics treated with insulin: an observational study
    Wouter T. Zandee
    Maria A. Sleddering
    Ingrid Jazet
    Petronella H.L.M. Geelhoed-Duijvestijn
    Aart H. Bootsma
    [J]. Nederlands Tijdschrift voor Diabetologie, 2011, 9 (3) : 107 - 107
  • [2] Real-world characteristics of patients with type 2 diabetes on basal insulin initiating add-on GLP-1 analogue therapy
    Dalal, M. R.
    Ling, Z.
    Davis, K. L.
    Meyers, J. L.
    DiGenio, A.
    [J]. DIABETOLOGIA, 2012, 55 : S403 - S404
  • [3] Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
    von Websky, Karoline
    Reichetzeder, Christoph
    Hocher, Berthold
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2013, 9 : 681 - 694
  • [4] GLP1-RA Add-on Therapy in Patients with Type 2 Diabetes Currently on a Bolus Containing Insulin Regimen
    Davies, Marie L.
    Pham, David Q.
    Drab, Scott R.
    [J]. PHARMACOTHERAPY, 2016, 36 (08): : 893 - 905
  • [5] GLP-1 based therapy for type 2 diabetes
    Arulmozhi, DK
    Portha, B
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 28 (1-2) : 96 - 108
  • [6] Addition of a GLP-1 Agonist to Insulin Therapy in Type 2 Diabetes
    Gavigan, Colleen
    Donner, Thomas W.
    [J]. DIABETES, 2021, 70
  • [7] The combination of insulin and GLP-1 analogues in the treatment of type 2 diabetes
    van der Klauw, M. M.
    Wolffenbuttel, B. H. R.
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 2012, 70 (10): : 436 - 443
  • [8] Comparison betweeen dapagliflozin add-on therapy and insulin dose escalation in patients with uncontrolled type 2 diabetes treated with insulin: DVI study
    Shin, Yujin
    Choi, Haeri
    Lim, Soo
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 175
  • [9] The impact of GLP-1 analogue liraglutide on type 2 diabetes patients with and without insulin therapy
    Haq, Z.
    Reidy, Y.
    Dempsey, M.
    Reidy, C.
    Keogh, A. M.
    Hoashi, S.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : S491 - S492
  • [10] Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study
    Ishihara, Hisamitsu
    Yamaguchi, Susumu
    Nakao, Ikko
    Sakatani, Taishi
    [J]. DIABETES THERAPY, 2018, 9 (04) : 1549 - 1567